2017 Fourth Quarter Earnings Conference Call
Wednesday, February 7, 2018, 5:00 p.m. ET
BETHLEHEM, Pa., Jan. 17, 2018 -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2017 fourth quarter financial results, 2018 first quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, February 7, 2018.
February 7, 2018 Schedule
| 4:00 p.m. ET | 2017 fourth quarter financial results press release will be distributed. |
| 4:50 p.m. ET | To participate in the conference call, dial 844-831-3030 (Domestic) |
| or 315-625-6887 (International) and reference Conference | |
| ID #5872026. | |
| 5:00 p.m. ET | Conference call and simultaneous Webcast begins. |
The conference call will also be webcast live and may be accessed on the Investor Relations page of OraSure’s website, www.orasure.com. Please click on the webcast link and follow the prompts for registration and access 10 minutes prior to the call.
If you are unable to participate, a replay of the call will be archived on OraSure’s website shortly after the call has ended and will be available for seven days. A replay of the call can also be accessed until midnight, February 14, 2018 by dialing 855-859-2056 (Domestic) or 404-537-3406 (International) and entering the Conference ID #5872026.
COMPANY CONTACT: Joni Messenlehner, OraSure Technologies, Inc. 610-882-1820, or [email protected].


Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Instagram Outage Disrupts Thousands of U.S. Users
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 



